CC
QNRX

Centiva Capital’s Quoin Pharmaceuticals QNRX Stock Holding History

Centiva Capital’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60,000
Closed -$396K – 2152
2026
Q1 		$396K Buy
60,000
+47,947
+398% +$434K ﹤0.01% 947
2025
Q4 		$174K Buy
+12,053
New +$164K ﹤0.01% 1011

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Centiva Capital's QNRX Position: Q2 2026 in Review

Centiva Capital sold out of Quoin Pharmaceuticals (QNRX) in Q2 2026, closing a stake of 60,000 shares — an estimated $396K sold.

Centiva Capital first reported a position in QNRX in Q4 2025 and held it in 2 quarters. The position peaked at $396K in Q1 2026. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Centiva Capital reported no remaining Quoin Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 60,000 Quoin Pharmaceuticals shares in Q2 2026, an estimated $396K.
  • Centiva Capital first reported a position in Quoin Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Centiva Capital's Quoin Pharmaceuticals position peaked at $396K in Q1 2026.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.